Mr. Adrian Mendes reports

PERIMETER SCHEDULES FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS CONFERENCE CALL FOR MARCH 31ST; PROVIDES CORPORATE UPDATE

Perimeter Medical Imaging AI Inc. will release its fourth quarter and full year 2025 financial and operating results after the market close on Tuesday, March 31, 2026. Following the release, Perimeter management will host a webcast and conference call to discuss the results and provide a corporate update.

fourth quarter and full year 2025 results conference call details

Date:  Tuesday, March 31, 2026

Time:  5 p.m. Eastern Time

Dial-in numbers:  1-800-717-1738 (Canada and the United States) or 1-646-307-1865 (international)

The call will also be broadcast live and archived on the company's website.

Warrant cancellation agreement

The company has entered into a warrant cancellation agreement with SC Master Holdings LLC (Social Capital), pursuant to which Social Capital has agreed to surrender 14,466,667 common share purchase warrants of the company for cancellation, for no consideration. Eighty per cent of the warrants had a strike price of $3.99 and 20 per cent of the warrants had a strike price of $4.50. Half of the warrants at each strike price were subject to accelerated expiry if the 60-day volume weighted average trading price of Perimeter's common shares is greater than the strike price during the applicable period. The other half of the warrants were not subject to accelerated expiry, and instead may have been exercised for cash or exercised using a cashless exercise feature at any time prior to expiry. Subject to the accelerated expiry clause described above, all warrants had an expiration date of Jan. 27, 2027.

Early warning disclosure as a result of the warrant cancellation

Prior to the cancellation of the warrants, Social Capital owned 29,089,337 common shares and 14,581,881 warrants, representing 22.2 per cent of Perimeter's outstanding common shares on a non-diluted basis and 30 per cent of the outstanding Perimeter common shares on a partially diluted basis, assuming exercise of the warrants. Following the cancellation of the warrants, Social Capital owns 29,089,337 Perimeter common shares and 115,214 warrants, representing 22.2 per cent of the outstanding Perimeter common shares on a non-diluted basis and 22.3 per cent of the outstanding Perimeter common shares on a partially diluted basis, assuming exercise of the warrants.

Social Capital holds the Perimeter common shares and warrants for investment purposes.

The foregoing disclosure is being disseminated pursuant to National Instrument 62-103, The Early Warning System and Related Take-Over Bid and Insider Reporting. A copy of the report to be filed with Canadian securities regulators in connection with the cancellation of the warrants will be available on Perimeter's SEDAR+ profile and a copy may be obtained by contacting Perimeter.

About Perimeter Medical Imaging AI Inc.

Based in Toronto, Canada, and Dallas, Tex., Perimeter is a medical technology company driven to transform cancer surgery with ultrahigh-resolution, real-time, advanced imaging tools to address areas of high unmet medical need. Claire, recently approved by the U.S. Food and Drug Administration (FDA), is the company's next-generation AI-enabled (artificial intelligence) device. The company's ticker symbol, PINK, is a reference to the pink ribbons used during breast cancer awareness month.